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Abstract
Background: Recent genome-wide association studies (GWASs) investigating bipolar disorder (BD) have detected a number
of susceptibility genes. These studies have also provided novel insight into shared genetic components between BD and
schizophrenia (SCZ), two major psychotic disorders. To examine the replication of the risk variants for BD and the pleiotropic
effect of the variants associated with BD, we conducted a genetic association study of single nucleotide polymorphisms
(SNPs) that were selected based upon previous BD GWASs, which targeted psychotic disorders (BD and SCZ) in the Japanese
population.
Methods: Forty-eight SNPs were selected based upon previous GWASs. A two-stage analysis was conducted using first-set
screening (for all SNPs: BD= 1,012, SCZ= 1,032 and control = 993) and second-set replication samples (for significant SNPs in
the screening analysis: BD= 821, SCZ= 1,808 and control = 2,149). We assessed allelic association between BD, SCZ,
psychosis (BD+SCZ) and the SNPs selected for the analysis.
Results: Eight SNPs revealed nominal association signals for all comparisons (Puncorrected,0.05). Among these SNPs, the top
two SNPs (associated with psychosis: Pcorrected = 0.048 and 0.037 for rs2251219 and rs2709722, respectively) were further
assessed in the second-set samples, and we replicated the signals from the initial screening analysis (associated with
psychosis: Pcorrected = 0.0070 and 0.033 for rs2251219 and rs2709722, respectively). The meta-analysis between the current
and previous GWAS results showed that rs2251219 in Polybromo1 (PBRM1) was significant on genome-wide association
level (P = 561028) only for BD (P = 9.461029) and psychosis (P = 2.0610210). Although the association of rs2709722 in Sp8
transcription factor (SP8) was suggestive in the Asian population (P = 2.161027 for psychosis), this signal weakened when
the samples size was increased by including data from a Caucasian population (P = 4.361023).
Conclusions: We found 3p21.1 (including PBRM1, strong linkage disequilibrium made it difficult to pinpoint the risk genes)
and SP8 as risk loci for BD, SCZ and psychosis. Further replication studies will be required for conclusive results.
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Introduction
Bipolar disorder (BD) is a severe mental condition, and the main
symptom is associated with abnormal affective status (i.e., a
patient’s mood will swing from manic to depression or vice-versa).
The prevalence of BD worldwide is greater than 1% [1,2], but the
precise molecular mechanism is largely unknown. Nevertheless,
epidemiological surveys have suggested that genetic factors
contribute substantially compared with the environmental factors,
and heritability has been estimated at 80% [3].
The results of genetic association studies, particularly genome-
wide association studies (GWASs), have identified an increasing
number of risk genes for susceptibility to BD. The initial meta-
analysis of the GWASs detected a single nucleotide polymorphism
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(SNP) in the a subunit of the L-type voltage-gated calcium channel
(CACNA1C) with suggestive statistical evidence for association
(P = 761028) [4]. This gene remains one of the most promising
genes for BD, as the most recent mega-analysis in the Psychiatric
GWAS Consortium (PGC) Bipolar Working Group provided
stronger evidence of association with the SNPs in CACNA1C
(P = 1.561028) [5]. This mega-analysis also detected another risk
SNP in Drosophila pair-rule gene ten-m (ODZ4) with genome-
wide significance (P= 4.461028), proposing a novel candidate
gene for BD [5]. Other studies based upon genome-wide screening
methodology identified several possible candidate genes for BD,
such as ankyrin 3 (ANK3) [4] and neurocan (NCAN) [6].
Interestingly, genetic association studies of schizophrenia (SCZ),
which is another major psychotic disorder, have also revealed that
the BD risk SNPs, such as CACNA1C and ANK3, are associated
with SCZ [7]. This result indicates that there is a shared genetic
component between BD and SCZ. Furthermore, several indepen-
dent lines of evidence converge to support this hypothesis: first,
polygenic component analysis, in which the cumulative number of
liberal risk alleles for SCZ or BD were enriched in the patients
with BD or SCZ [8], and second, epidemiological studies, in which
relatives of a proband with BD also had elevated risk for SCZ in
addition to BD [9]. Therefore, combining BD and SCZ samples
into a single psychosis group [10] can provide increased statistical
power, specifically for the detection of overlapping risk SNPs.
Several studies have used this concept also enhance detection of
risk SNPs for either BD or SCZ [11,12].
The goal of the current study was to conduct replication and
cross-phenotype analyses of the SNPs that were selected based
upon BD GWAS findings with two psychotic disorders (BD and
SCZ) in the Japanese population. We used a two-stage design
(screening and replication samples) and a meta-analysis approach
to obtain reliable results.
Materials and Methods
Ethics Statement
Written informed consent was obtained from each subject after
the procedures had been fully explained. This study was
performed in accordance with the World Medical Association’s
Declaration of Helsinki and approved by the ethics committees at
Fujita Health University, RIKEN BSI and institutes participating
in the Collaborative Study of Mood Disorder (COSMO) [13].
Subjects
We used two independent sample sets in this study. In the first-
set screening analysis, we examined 1,012 patients with BD
[51.8% female, age 6 standard deviation (SD) = 50.7 6
14.3 years, BD type I = 621, BD type II = 380, schizoaffective
disorder (SA) = 7, BD type information not available = 4], 1,032
SCZ (48.3% female, mean 6 SD=46.8 6 14.8 years) and 993
healthy controls (51.1% female, age 6 SD=49.7 6 14.0 years).
For the two SNPs that showed a significant association in the
screening analysis, we used an independent second-set of samples
for replication analysis. This sample consisted of 821 patients with
BD (54.6% female, age 6 SD=48.2614.4, BD type I = 387, BD
type II = 344, SA= 89, BD type information not available = 1),
1,808 patients with SCZ (45.1% female, age 6
SD=49.8614.8 years) and 2,149 healthy controls (58.3% female,
age 6 SD=42.3614.2 years). A detailed description of our
subjects, including a general characterization and psychiatric
assessment, is described elsewhere [13].
T
a
b
le
2
.
m
e
ta
an
al
ys
is
o
f
th
e
tw
o
SN
P
s
d
e
te
ct
e
d
in
th
e
fi
rs
t-
se
t
sc
re
e
n
in
g
an
al
ys
is
.
P
v
a
lu
e
o
f
o
ri
g
in
a
l
st
u
d
y
cu
rr
e
n
t
st
u
d
y
(s
cr
e
e
in
g
+r
e
p
li
ca
ti
o
n
)
cu
rr
e
n
t
st
u
d
y
+P
G
C
B
P
cu
rr
e
n
t
st
u
d
y
+L
e
e
e
t
a
l.
cu
rr
e
n
t
st
u
d
y
+L
e
e
e
t
a
l.
+P
G
C
B
P
C
h
r
S
N
P
G
E
N
E
A
1
a
A
2
b
P
G
C
B
P
L
e
e
e
t
a
l.
c
p
h
e
n
o
ty
p
e
d
P
O
R
e
I2
P
O
R
e
I2
P
O
R
e
I2
P
O
R
e
I2
3
rs
2
2
5
1
2
1
9
P
B
R
M
1
A
G
5
.5
E-
0
7
-
B
D
0
.0
0
4
8
1
.1
3
0
9
.4
E-
0
9
1
.1
3
0
SC
Z
0
.0
0
0
1
6
1
.1
5
0
4
.3
E-
1
0
1
.1
3
0
P
sy
ch
o
si
s
8
.0
E-
0
5
1
.1
4
0
2
.0
E-
1
0
1
.1
3
0
7
rs
2
7
0
9
7
2
2
SP
8
T
C
0
.0
8
9
5
.0
6
E-
0
5
B
D
0
.0
0
1
6
0
.8
6
0
0
.0
3
2
2
0
.9
1
5
6
.2
5
.1
E-
0
7
0
.8
4
0
0
.0
0
7
0
0
.8
8
7
2
.9
SC
Z
0
.0
0
3
0
0
.8
9
4
6
.6
0
.0
3
3
2
0
.9
2
5
8
.4
1
.6
E-
0
6
0
.8
6
4
2
.2
0
.0
0
7
4
0
.8
9
7
3
.9
P
sy
ch
o
si
s
0
.0
0
0
4
0
0
.8
8
3
2
.4
0
.0
2
1
2
0
.9
1
6
4
.6
2
.1
E-
0
7
0
.8
6
3
0
.3
0
.0
0
4
3
0
.8
9
7
4
.7
a:
A
1
:
fi
rs
t
al
le
le
co
d
e
.
b
:
A
2
:
se
co
n
d
al
le
le
co
d
e
.
c:
Le
e
e
t
al
.
re
p
o
rt
e
d
th
e
P
va
lu
e
s
b
as
e
d
u
p
o
n
d
o
m
in
an
t
m
o
d
e
l.
T
o
co
n
d
u
ct
m
e
ta
-a
n
al
ys
is
o
f
al
le
lic
m
o
d
e
l,
w
e
re
-c
al
u
cu
la
te
d
P
va
lu
e
s
b
as
e
d
u
p
o
n
th
e
ir
re
su
lt
s.
d
:
B
D
:
b
ip
o
la
r
d
is
o
rd
e
r,
SC
Z
:
sc
h
iz
o
p
h
re
n
ia
.
e
:
th
e
e
ff
e
ct
is
w
it
h
re
sp
e
ct
to
th
e
A
1
al
le
le
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
7
0
9
6
4
.t
0
0
2
SNPs on 3q21 and in SP8 Associated with Psychosis
PLOS ONE | www.plosone.org 3 August 2013 | Volume 8 | Issue 8 | e70964
SNP selection and quality control
We selected 48 SNPs from BD GWAS data published prior to
September 2011 [4,5,6,14,15,16,17,18,19,20]. Regarding SNP
selection, we used the following inclusion criteria. The potential
risk SNPs in autosomal chromosomes must have had a P-value less
than 161025 if the original GWAS was conducted using a
Caucasian population. The P-value must have been less than
161024 if the study was based upon Asian population or PGC [5].
The minor allele frequency (MAF) must not have been equal to
zero based upon the HapMap JPT panel. We used a Sequenom
iPLEX Gold System (Sequenom, San Diego, CA) genotyping
platform. In the optimization step, two SNPs (rs10193871 and
rs1012053) were excluded due to a primer design problem.
Moreover, because a visual inspection of the clustering revealed
that six SNPs did not yield acceptable genotyping calls, we
designed new primers for their proxy SNPs (N= 8) based upon
tight linkage disequilibrium (LD). However, at this stage, we could
not obtain optimal clustering for three of these SNPs. In total, we
analyzed 45 SNPs (Figure S1 and Table S1). The quality control
(QC) was conducted based upon the following criteria: (1) the
missing call rate per person (less than 10%); (2) the missing call rate
per SNP (less than 5%); and (3) a Hardy-Weinberg Equilibrium
(HWE) P.0.0001 threshold (Table S1).
Statistical analysis
We assessed the allelic association of the SNPs and the following
three phenotypes: 1) BD (referred to as BD association); 2) SCZ
(referred to as SCZ association); and 3) psychosis (BD+SCZ;
referred to as psychosis association) (Figure S2 and S3).
A comparison between multiple variables is a major concern to
be addressed in a genetic study in which multiple SNPs and
phenotypes are analyzed. However, thus far, no gold standard has
been established. Therefore, we used a two-stage analysis and
stringent cut-off level for the type I error rate in the first-set
screening sample. LD between SNPs selected for analysis was
calculated by SNPSpD program [21,22] to establish an effective
number of independent variables (N= 36.06). We used an adjusted
statistical significance level (P,0.00138) based upon this number
of independent variables. The associated SNPs from the first-set
screening samples were followed-up and genotyped to replicate the
association in the independent second sample set. In these analyses
(first-set and second-set analyses), a one-tailed analysis was applied
under a unidirectional hypothesis that risk alleles identified in the
original studies were associated with risk in our dataset. We
assumed this association because most of the original studies that
we referred to used a larger number of subjects than those in our
screening datasets [11].
A meta-analysis was conducted by combining the screening, the
replication and/or the original datasets. It is worth noting that if
the original dataset was involved in the PGC mega-analysis of BD,
we used PGC results for the meta-analysis. A fixed model (if the I2
heterogeneity index was less than 50) or random effect model (if
the I2 heterogeneity index was greater than 50) was applied in each
analysis. All of the statistical procedures were calculated using
PLINK version 1.07 [23].
Results
Replication analysis of the BD GWAS SNPs with BD, SCZ
and psychosis in the Japanese population
After the QC calculations, 42 SNPs and 2,759 samples in the
first-set screening samples were eligible for the association analysis
(916 patients with BD, 946 patients with SCZ and 897 healthy
controls). Table 1 lists the results, which indicated a nominal
association signal (uncorrected P,0.05). Complete results are
presented in Table S2. It is of note that all of the SNPs that had a
nominal association with the BD sample (BD association), were
also associated with SCZ (SCZ association), thus the P-values for
psychosis (psychosis association) are more significant (Table 1).
In the analysis of BD association and psychosis association, the
most significant association maps to the Sp8 transcription factor
(SP8) locus (rs2709736: uncorrected P= 0.0055 for BD, and
rs2709722, uncorrected P= 0.0010 for psychosis), which is the
same direction as the original Taiwanese population-based study
[16]. However, in the analysis of SCZ association, the strongest
association signal maps to chromosome 3 (52–53 Mb) and
rs2251219 (uncorrected P= 0.0018) in the polybromo 1 gene
(PBRM1).
Only two SNPs (rs2709722 in SP8 and rs2251219 in PBRM1)
within the psychosis set remained significant after the multiple
comparison correction (corrected P= 0.037 and 0.048 for
rs2709722 and rs2251219, respectively). Thus, we performed a
replication analysis of these two SNPs using an independent
second set of samples with BD and SCZ. The associations of both
SNPs were replicated, indicating a significant association with
psychosis (corrected P= 0.033 and 0.0070 for rs2709722 and
rs2251219, respectively). However, the SP8 SNP (rs2709722) and
PBRM1 SNP (rs2251219) revealed only a nominal association level
with BD or SCZ (0.01,corrected P,0.1, Table 1).
Meta-analysis of the significant SNPs detected in the first-
set screening samples combining the results from our
current study and the original study
In the meta-analysis, we combined our two datasets (the first-set
screening samples and second-set replication samples) for the two
SNPs (rs2709722 and rs2251219) to assess the association for only
the Japanese population. We obtained stronger evidence of
association in all of the sample sets (Table 2). Specifically, results
from the psychosis sample had the most significant association
(P= 8.061025 for rs2251219 and P= 4.061024 for rs2709722).
We then combined the results from the original study [16] and/
or PGC [5] datasets. For rs2251219, the original study by
McMahon et al. [17] reported that the association was included in
the PGC [5]; thus, we only combined the PGC results. The
original study by Lee et al. [16] showed significance for rs2709722
based upon a dominant model. To conduct this meta-analysis, we
recalculated the allele-wise P-value based upon the allele
frequency information. For rs2251219, we detected an association
with a genome-wide significance level only in the BD
(P= 9.461029), SCZ (P= 4.3610210) and psychosis sets
(P = 2.0610210). Stronger evidence for rs2709722 was obtained
in the meta-analysis (the current study and Lee’s results [16]) (BD
only: P= 5.161027, SCZ only: P = 1.661026, psychosis:
P = 2.161027), although this signal weakened the sample size
was increased by including data from a Caucasian population
(results from the current, Lee et al. and PGC studies: BD only:
P= 0.0070 SCZ only: P= 0.0074 and psychosis: P = 0.0043:
Table 2).
Discussion
In this study, we conducted a two-stage association analysis of
the promising risk SNPs based upon BD GWASs with BD, SCZ
and psychosis samples from a Japanese population. Two SNPs
were detected with significant associations in the all of the
phenotypes from the first-set screening (if uncorrected for multiple
comparison) and second-set replication samples, indicating that
these SNPs may play a role as a common risk factor for both BD
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and SCZ. Furthermore, we detected an association on a genome-
wide significance level within the PBRM1 locus (rs2251219) by
combining the results from the recent mega-analysis, which used
the largest sample size thus far [5].
The SNP rs2251219, which maps to the PBRM1 locus, was
originally reported in a meta-analysis of BD and major depressive
disorders in a Caucasian population (P = 1.761029) [17]. This
SNP was also reported in the PGC BD as possessing a suggestive
level of association (P= 5.561027) [5]. Our meta-analysis supports
this finding regarding BD because we detected a genome-wide
significance (P = 9.461029), even when the BD set was analyzed
alone. It is also of note that the results of this meta-analysis
merging our SCZ/psychosis sets and PGC BD showed genome-
wide significance (SCZ and PGC BD: P= 4.3610210, psychosis
and PGC BD: P=2.0610210).
Interestingly, rs2251219 is in LD with another SNP (rs1042779,
base position = 52.8 Mb) in inter-alpha-trypsin inhibitor heavy
chain 1 (ITIH1), which was examined in our screening sample
(D’ = 0.96 and r2 = 0.84 in an Asian population in the 1000
genome database as a reference panel) and revealed a nominal
association (uncorrected P,0.05 for all phenotypes). This region
(3p21.1) is one of the most attractive loci as a candidate region for
risk for psychotic disorders. A recent study by Hamshere et al. [11]
reported that SNP (rs2239547) in inter-alpha-trypsin inhibitor
heavy chain 3 and 4 (ITIH3-4) was significantly associated with
BD and/or SCZ at a genome-wide significance level (D’ = 0.95
and r2 = 0.58 with rs2251219, Asian population in the 1000-
genome database as a reference panel). The most recent study by
the PGC Cross-Disorder Group (CDG) also reported that SNP
(rs2535629) in ITIH3-4 was associated with five psychiatric
disorders, and the strongest association was observed in the BD
set [12]. These SNPs located in and around PBRM1, ITIH1 and
ITIH3-4 are in strong LD. Thus, all of the SNPs in this LD block
are promising candidates for genetic risk for BD, SCZ or
psychosis. This LD structure in turn indicates that it is difficult
to narrow down the true susceptibility variants within this region
(Figure S4).
A Taiwanese BD GWAS found a suggestive association signal
that maps to the SP8 locus (P = 4.861027 in dominant model)
[16]. Our result supports the association of this gene with BD,
specifically for Asian populations. The meta-analysis of our results
and Lee’s results indicated a stronger association signal that was
weakened when the sample size was increased by including data
from a Caucasian population (Table 2). Considering the results of
the heterogeneity test (in which the I2 score significantly increased
by combining PGC BD dataset), the SP8 gene may play a role as a
population-specific risk gene in individuals of Asian ancestry. SP8
is a SP transcription factor and functions in neural development by
interacting with Wnt/beta-catenin and fibroblast growth factor
(FGF) signaling [24]. Because there are no studies that have
examined the association between SP8 and BD/SCZ, further
research is needed to better understand the relationship between
SP8 and psychiatric disorders. Special attention is needed
regarding the population-specific effect that rs2709722 might
have.
SNPs located in other promising candidate genes were not
significantly associated with BD, SCZ or psychosis in the Japanese
population. Although a trans-population effect is a likely
explanation, our sample size may not have sufficient power to
observe the association compared with the estimated effect size
(odds ratio (OR) of ,1.2). The analysis of the power of our study
[25] indicated that our sample had 25% power for BD/SCZ and
40% for psychosis to detect significance (assuming an OR of 1.2) of
risk with 25% MAF (average MAF in our examined SNPs in the
control subjects) under an additive model (type I error
rate = 0.00138). Therefore, a larger sample size in future work is
essential.
In conclusion, we found two loci, PBRM1 (and neighboring
genes) and SP8, that were replicated in psychotic disorders in a
Japanese population. Specifically, a SNP within PBRM1 revealed
genome-wide significance in the meta-analysis, suggesting prom-
ising candidate genes for BD. SP8, which was not significant on a
genome-wide level, is still a candidate for a population-specific risk
factor for BD.
Supporting Information
Figure S1 SNP selection strategy. JPT: HapMap Japanese
Tokyo sample HWE: Hardy-Weinberg Equilibrium.
(TIF)
Figure S2 Sample numbers in the first-set screening
samples. BD: Bipolar disorder SCZ: Schizophrenia.
(TIF)
Figure S3 Sample numbers in the second-set replication
samples. BD: Bipolar disorder SCZ: Schizophrenia.
(TIF)
Figure S4 Linkage disequilibrium structure around
3q21 in the Asian population. Data are from HapMap JPT
and CHB. The LD measure is based upon D’.
(TIF)
Table S1 SNPs selected based upon previous BD GWAS.
(XLSX)
Table S2 Association analysis for all SNPs.
(XLSX)
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